Advertisement

Topics

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

2018-01-16 09:55:10 | BioPortfolio

Published on BioPortfolio: 2018-01-16T09:55:10-0500

Clinical Trials [3894 Associated Clinical Trials listed on BioPortfolio]

Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants

Human parainfluenza virus type 2 (HPIV2) can result in severe respiratory illness in infants and young children. This study will test the safety of and immune response to an HPIV2 vaccine ...

Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults

Human metapneumovirus (HMPV) is a virus that can cause respiratory illness. In older adults, those with asthma, infants, and children, illness can be severe, but in healthy adults the viru...

Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus

The purpose of this study is to determine in hospitalized adult participants infected with human metapneumovirus (hMPV - a virus closely related to respiratory syncytial virus (RSV) and ha...

Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

Human parainfluenza viruses (HPIVs) are a major health concern in infants and young children under 5 years of age, causing serious respiratory tract disease. The purpose of this study is t...

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

RATIONALE: Vaccines made from human papillomavirus may help the body build an effective immune response to kill HIV cells. PURPOSE: This phase II trial is studying the side effects and ho...

PubMed Articles [26416 Associated PubMed Articles listed on BioPortfolio]

RNAi Targeting of Human Metapneumovirus P and N Genes Inhibits Viral Growth.

Human metapneumovirus (hMPV) is an important human respiratory pathogen and is implicated in an array of respiratory illnesses, ranging from asymptomatic infection to severe bronchiolitis. Currently, ...

Characterization of human parainfluenza virus-3 circulating in Israel, 2012-2015.

Human parainfluenza virus 3 (hPIV-3) causes respiratory tract infection.

Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Asthmatic Children.

Human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) are the leading causes of acute respiratory illness in children. Clinical burden of each infection on the respiratory distress in ast...

Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis.

Human metapneumovirus (hMPV) has been identified as a major cause of lower respiratory tract infection in children. Epidemiological and molecular evidence has highlighted an association between severe...

Skewed balance of regulatory T cell and inflammatory T cell in IL-17 defect with human metapneumovirus infection.

Human metapneumovirus (hMPV) is a common cause of respiratory infections in children. However, the precise mechanisms underlying the development of hMPV-induced pulmonary pathology remain unknown. Stu...

Medical and Biotech [MESH] Definitions

A genus of the subfamily PNEUMOVIRINAE, containing two members: Turkey rhinotracheitis virus and a human Metapneumovirus. Virions lack HEMAGGLUTININ and NEURAMINIDASE.

An acute inflammatory disease of the upper RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.

Vaccines or candidate vaccines used to prevent infection with parainfluenza viruses in humans and animals.

A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia.

A species of RUBULAVIRUS associated particularly with acute laryngotracheitis (CROUP) in children aged 6 months to 3 years.

More From BioPortfolio on "Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial